Resveratrol has been reported in animal and human studies to reduce and ameliorate the progression of various autoimmune diseases, including rheumatoid arthritis and systemic lupus erythematosus.
Does resveratrol improve the progression of autoimmune diseases in animal models and humans?
Resveratrol exhibits anti-inflammatory and antioxidant properties that may ameliorate the progression of various autoimmune diseases.
Autoimmune diseases are still considered to be pressing concerns due the fact that they are leaders in death and disability causes worldwide. Resveratrol is a polyphenol derived from a variety of foods and beverages, including red grapes and red wine. Anti-inflammatory, antioxidant, and antiaging properties of resveratrol have been reported, and in some animal and human studies this compound reduced and ameliorated the progression of autoimmune diseases, such as rheumatoid arthritis, systemic lupus erythematosus, psoriasis, inflammatory bowel disease, and type 1 diabetes mellitus. Thus, this review aims to summarize and critically analyze the role of resveratrol in the modulation of several organ-specific or systemic autoimmune diseases.
Oliveira et al. (Fri,) conducted a review in Autoimmune diseases. Resveratrol was evaluated. Resveratrol has been reported in animal and human studies to reduce and ameliorate the progression of various autoimmune diseases, including rheumatoid arthritis and systemic lupus erythematosus.